PLK1 and ovarian carcinoma: Importantly, pharmacological induction of strong mitotic arrest via PLK1 inhibition and microtubule targeting followed by blocking mitotic exit activates apoptosis, prevents endoduplication and reduces chromosomal instability in an ovarian cancer cell line culture system [273].